EFSD/Lilly Research Fellowship Programme
EFSD/Lilly Research Fellowship Programme
2017
Amin Ardestani: University of Bremen - Germany
Targeting hippo effector YAP for beta cell protection in diabetes
Daniele Barbato: University of Rome Tor Vergata - Italy
ProBATion: Mapping nanovesicles-vehicled Proteins released from Brown Adipose Tissue
Rongrong Fan: Karolinska Institute - Stockholm, Sweden
Encrypting the role of macrophage GPS2 in the development of T2D complications
Marta Guasch-Ferré: Pere Virgili Health Research Institute - Reus, Spain
Mechanisms underlying metabolomic profiles and type 2 diabetes
Ka-Cheuk Liu: Karolinska Institute – Stockholm, Sweden
Screen for enhancers of beta cell neogenesis – and follow up on a role for cdk5
Annika Mehlem: Karolinska Institute - Stockholm, Sweden
Inhibition of vascular endothelial growth factor B (VEGF-B), keeping lipids where they belong?
Teresa Mezza: Catholic University of the Sacred Heart - Rome, Italy
Investigating the role of intra-islet GLP-1 production in the modulation of islet plasticity in humans
Ivana Nikolić: Spanish National Center for Cardiovascular Research - Madrid, Spain
Adipose p38delta in control of body metabolism
2016
Maria Rosaria Ambrosio: University of Naples "Federico II" - Italy
Identification of novel glucose-regulated communication signals involved in breast cancer chemoresistance
Jesus Blanco: IDIBAPS - Barcelona, Spain
Mechanisms underlying the formation of beta cell autoantigen-specific regulatory networks in vivo
Jorge Correira: Karolinska Institute - Stockholm, Sweden
Role of Zfp697 in inflammation and metabolic disease
Rodolphe Dusaulcy: University of Geneva Medical School - Switzerland
Role of micro RNAs in pancreatic alpha cells function during type 2 diabetes
Gian Paolo Fadini: Venetian Institute of Molecular Medicine - Padua, Italy
How diabetes affects neutrophil pro-angiogenic phenotype, senescence and NETosis in mice and humans
Kathrin Gaens: Maastricht University - The Netherlands
Obesity-associated hypoxia is a key player in AGE formation and development of type 2 diabetes mellitus
Nikhil Gandasi: Uppsala University - Sweden
Rate limiting factors for sustained insulin secretion from human pancreatic beta cells
Nordin Hassen: Maastricht University - The Netherlands
Are plasma dicarbonyl levels associated with incident cardiovascular disease in type 1 and type 2 diabetes?
Aurora Mazzeo: University of Turin - Italy
Role(s) of circulating extracellular vesicles in pathogenesis and repair of diabetic complications
2015
Caroline Arous: University of Geneva - Switzerland
Adhesions-mediated control of insulin secretion in beta cells
Elise Dalmas: University of Basel - Switzerland
IL-33-induced type 2 immunity in pancreatic islets: role in physiology and diabetes
Sonia Fernández-Veledo: Pere Virgil Health Research Institute - Tarragona, Spain
Central effects of GLP-2R activation: insights into a potential brain-gut-adipose tissue cross-talk
Luca Parrillo: Federico II University of Naples - Italy
Identification of epigenetic signatures underlying increased risk of type 2 diabetes
Xavier Prieur: University of Nantes - France
Deciphering seipin function in the mature adipocyte
Kim Ravnskjaer: University of Southern Denmark - Odense M, Denmark
In situ analysis of hepatic stellate cell signalling in the development of hepatic fibrosis
Mark Russell: University of Exeter - UK
Subcellular localisation of cell cycle regulatory proteins in human beta cells: is the current paradigm correct?
Nicolas Venteclef: Cordeliers Research Centre - Paris France
Characterisation of the immuno-metabolic roles of Interferon regulatory factor 5 in type 2 diabetes
2014
Céline Cruciani-Guglielmacci: Paris Diderot University - France
Does triglyceride lipase activity in hypothalamus control blood glucose homeostasis?
Isabel Göhring: Charité University Medicine Berlin - Germany
Novel regulars of glucose sensing and insulin secretion in pancreatic beta cells
Veronica Jimènez: Autonomous University of Barcelona - Spain
Therapeutic approaches against type 2 diabetes and obesity targeting adipose tissue with factors that increase energy expenditure
Troy Merry: ETH Zurich - Schwerzenbach, Switzerland
The role of nuclear factor (erythroid-derived 2)-like 2 in exercise-induced metabolic adaptions
Jonas T Treebak: University of Copenhagen - Denmark
Role of NAD-salvage systems for mitochondrial function and insulin sensitivity: implications for type 2 diabetes
2013
Paloma Alonso-Magdalena: Miguel Hernandez University - Elche, Spain
Exposure to endocrine disruptor chemicals during pregnancy: a possible mechanism involved in the premature ageing of maternal pancreatic beta cells
Jordi Altirriba: University of Geneva - Switzerland
Oxytocin effects on adipose tissue inflammation and its impact on insulin resistance
Yvonne Böttcher: University of Leipzig - Germany
Promotor methylation of glucose transporter 4 (GLUT4) in human subcutaneous and visceral adipose tissue
Josep Mercador: Technical University of Catalonia - Barcelona, Spain
Systems biology genome-wide association studies to identify novel type 2 diabetes molecular mechanisms
Emma Nilsson: Lund University - Malmö, Sweden
The role of microRNAs in the development of insulin resistance and type 2 diabetes
Francesco Ortega: Biomedical Research Institute of Girona - Spain
Circulating microRNAs in pre-pubertal children as biomarkers of metabolic diseases such as type 2 diabetes
Janna van Diepen: Radboud University - Nijmegen, The Netherlands
Macrophage activation in patients with diabetes: increasing the risk for atherosclerosis
2012
Lisa Berglund: Lund University - Malmö, Sweden
Role of the incretin hormone GIP in the development of diabetic vascular complications - good or bad?
Maarten Brom: Radboud University - Nijmegen, The Netherlands
Determination of the beta cell mass by SPECT with ¹¹¹ In-exendin in a rat model for type 2 diabetes
Paul Caton: Queen Mary University - London, UK
The role of nicotinamide adenine dinucleotide synthesis in mediating islet-compensation to insulin resistance
Marc Claret: IDIBAPS - Barcelona, Spain
Mitochondrial fusion protein Mitofusin 1 in POMC neurons: potential regulator of energy homeostasis
Jonathan Esguerra: Lund University - Malmö, Sweden
Characterisation of non-coding RNAs in pancreatic islets and microRNAs as blood-based biomarkers in diabetes
Bruno Guigas: Leiden University Medical Center - The Netherlands
Protective effects of parasite-derived molecules in metabolic disorders
Laura Herrero: University of Barcelona - Spain
Enhancing brown adipose tissue fat-burning power as a therapy against obesity-induced diabetes
Shahram Hedjazifar: Lundberg Laboratory for Diabetes Research - Göteborg, Sweden
The role of WISP2, a Wnt-related molecule, in recruitment and differentiation of brown adipocytes - a thereupeutic approach for obesity and type 2 diabetes
Philippe Klee: University Hospital of Geneva – Switzerland
Identification of the molecular mechanisms involved in beta cell protection by cholinergic agonists
Anna Motterle: University of Lausanne – Switzerland
Contribution of long non-coding RNAs in the development of type 2 diabetes
Joris Robben: Radboud University – Nijmegen, The Netherlands
Involvement of the succinate receptor SUCNRI in diabetes-associated damage of kidney, liver and eye
Tamás Röszer: Spanish National Cardiovascular Research Centre - Madrid, Spain
Macrophage specific targeting of retinoid x receptors: role in type 2 diabetes
2011
Romain Barrés: University of Copenhagen - Denmark
The role of transient DNA hypomethylation on muscular adaptation
Federica Barutta: University of Turin - Italy
AM6545 and AM1241 in the prevention/treatment of experimental diabetic nephropathy
Vladimer Darsalia: Karolinska Institute - Stockholm, Sweden
VPAC2 receptor activation for the treatment of stroke in diabetes
Lorenzo Pasquali: IDIBAPS - Barcelona, Spain
Mapping the human pancreatic islet-cell cis regulome
Matthew Simmonds: University of Oxford - UK
Identifying the genetic predictors of graft function in whole organ pancreas transplantation
Tom Van Belle: Ghent University - Belgium
How does 1,25 dihydroxyvitamin D3 (1,25(OH)2D3) act on immune cells during autoimmunity?
Nicholas Venteclef: Pierre and Marie Curie University - Paris, France
Cathepsin S as modulator of glucose homeostasis: depicting its molecular actions in hepatocytes
2010
Stefan Amisten: University of Oxford - UK
Quantification of all G-protein coupled receptors in human pancreatic islets, alpha- and beta cells
Christian Andersson: Sahlgrenska University - Gothenburg, Sweden
Regulation of IL-6 signalling and the inflammation response
Céline Cruciani-Guglielmacci: University Paris Diderot - France
Involvement of triglycerides and lipoproteins hydrolysis in rat hippocampus in the control of energy balance
Heidi de Wet: University of Oxford - UK
An investigation of the sulfonylurea sensitivity of KATP channels carrying mutations causing neonatal diabetes
Victorine Douin: Rangueil Hospital, -Toulouse, France
Role of intestinal dendritic cells in the onset of high-fat diet-induced inflammation and type 2 diabetes
Gianpaolo Fadini: University of Padova - Italy
Clinical data-driven research of new stem cell-mobilising agents for vascular repair in diabetes
Melis Karaca: University of Geneva - Switzerland
Genetic abrogation of the amplifying pathway in pancreatic beta cells: effects on diet-incuded obesity
Eckhard Lammert: Heinrich-Heine University - Düsseldorf, Germany
Investigation of the role of DJ-1 in glucose tolerance and glucose stimulated insulin secretion from pancreatic islets
Joan-Marc Servitja: IDIBAPS -Barcelona, Spain
Epigenetic control of gene expression in pancreatic islets
Barbara Ukropcova: Slovak Academy of Sciences -Bratislava, Slovakia
Metabolic health and muscle secretory profile in aerobic and resistance trained obese pre-diabetic individuals
2009
Marie Björnholm: Karolinska Institutet - Stockholm, Sweden
Leptin receptor signalling - integration of central and peripheral effects
Ann Hammarstedt - The Lundberg Laboratory - Gothenburg, Sweden
WISP-2 - a novel adipokine related to obesity and insulin resistance
Paolo Rossetti: University of Perugia - Italy
Restoration of glucagon response to insulin induced hypoglycaemia in type 1 diabetes mellitus subjects: the role of the amino acids
Giovanni Solinas: University of Fribourg - Germany
Investigating the role of phosphoinositide-3 kinase γ in diet-induced obesity and insulin resistance
2008
Ferdinando Giacco: Federico II University - Italy
Effect of "metabolic memory" and ROS production on bone marrow endothelial progenitor (EPCs) function
Lina Lauffer: University of Toronto -Canada
The role of GPR119 and OEA in the regulation of GLP-1 secretion
2007
Aouatef Ait-Lounis: University of Geneva - Switzerland
Role of the transcription factor RFX3 and cilia in the function of beta cells
Justo Sierra Johnson: Karolinska University Hospital - Sweden
Effects of physical activity on the metabolic syndrome and gene expression in adipose tissue
2006
Karim Bouzakri: Geneva University - Switzerland
Synergistic signalling by hormones and ECM acting on beta-cell function, replication and survival
Sarah Longnus: Nice University Hospital - France
AMPK, a potential therapeutic target for improving myocardial glucose use in diabetes?